Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
Infection and Chemotherapy
;
: 253-256, 2014.
Article
in English
| WPRIM
| ID: wpr-116973
ABSTRACT
We investigated the antibiotic susceptibility of glycopeptide-resistant enterococci (GRE). Seventy consecutive GRE were tested. Sixty-two isolates were identified as Enterococcus faecium (88.6%), and 8 (11.4%) as Enterococcus faecalis. All strains were susceptible to linezolid and daptomycin, while 17.1% (12/70) and 11.4% (8/70) were resistant to quinupristin/dalfopristin (QD) and tigecycline, respectively. All E. faecalis isolates were resistant to QD, while 4 of 62 (6.5%) E. faecium isolates were resistant to QD. All E. faecalis isolates were susceptible to tigecycline, while 14.5% (9/62) E. faecium isolates were resistant. Continued surveillance of GRE antibiotic susceptibilities is important for combating these multi-resistant nosocomial pathogens.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Enterococcus faecium
/
Enterococcus faecalis
/
Teicoplanin
/
Daptomycin
/
Linezolid
Language:
English
Journal:
Infection and Chemotherapy
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS